American CryoStem's ATGRAFT Adipose Tissue Storage Platform To Be Licensed In Japan

American CyroStem (OTC PINK:CRYO) has entered into an agreement to licence its ATGRAFT adipose tissue (fat) processing storage technologies with Cell Source (CS) in Japan.
According to the press release:

American CryoStem has licensed to CS the rights to utilize the Company’s Standard Operating Procedures (SOP’s) to create and market the Company’s ATGRAFT™ tissue storage service in Japan. The financial terms call for an upfront licensing fee, annual minimum licensing payments and the purchase of CRYO’s ACSelerate™ non-DMSO cryogenic tissue storage media and Cellect™ tissue collection kit and other required consumables for sample processing. Upon execution, CRYO received the first year annual licensing fee.

John Arnone, CEO of American CryoStem, commented:

We are pleased to announce another international licensing agreement for our ATGRAFT tissue storage platform. This agreement will be the second licensing agreement and the third laboratory facility utilizing CRYO’s technology in the Asian market. This license furthers our corporate mission to establish a global network of laboratories operating under a standardized platform and utilizing our consumables for processing.

Click here to red the full American CryoStem press release.